Stay updated on Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial page.

Latest updates to the Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check15 days agoChange DetectedThe latest revision in the record history is now v3.5.4, replacing the previous v3.5.3. This reflects an administrative update to the page metadata.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedA minor update to the ClinicalTrials.gov page revision/version label is reflected (v3.5.2 → v3.5.3) without corresponding changes to the trial’s displayed record history content.SummaryDifference0.1%

- Check43 days agoChange DetectedThe history now shows a new Revision: v3.5.2 and removes the prior Revision: v3.5.0.SummaryDifference0.1%

- Check72 days agoChange DetectedSponsor information (Hellenic Society of Hematology), verification status, and last known status (Recruiting) were added for the 2023-11 update. The record history revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.9%

- Check79 days agoChange DetectedA new revision, v3.4.3, has been added to the study record history and the previous revision v3.4.2 has been removed.SummaryDifference0.1%

- Check107 days agoChange DetectedA new revision entry (v3.4.2) was added to the study history. The funding-lapse notice and the previous revision entry (v3.4.1) were removed.SummaryDifference0.9%

Stay in the know with updates to Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Combo in Newly Diagnosed Myeloma Clinical Trial page.